SUBSTANDARD GENERIC DRUGS

June 17, 2019

According to an official document, the Bureau of Pharma PSUs of India (BPPI) has found 25 batches of drugs of 18 pharmaceutical companies to be of substandard quality since January 2018.

Key highlights of the document:

  • BPPI has found 25 batches of drugs of 18 pharmaceutical companies to be of substandard quality since January 2018.

  • While 17 out of the 18 companies are private, one is a public sector unit (PSU), the Indian Drugs and Pharmaceuticals Limited (IDPL).

  • Of these, seven companies have been blacklisted for two years i.e. they are barred from supplying generic drugs to Janaushadhi scheme.

Source : The Hindu